secwatch.observer — SEC 8-K summary
======================================

Issuer:     HARROW, INC. (HROW)
CIK:        0001360214
Form:       8-K
Filed at:   2024-03-21T23:59:59+00:00
Accession:  0001493152-24-010740
Event type: regulatory
Sentiment:  positive
Materiality: 0.70
Item codes: 8.01
LLM model:  deepseek-v4-flash:cloud@v2

CMS increases MUE for Harrow's IHEEZO J-Code from 1 to 2, effective July 2024 retroactive to Jan 1, 2024
--------------------------------------------------------------------------------

- CMS approved increase of Medically Unlikely Edit (MUE) for IHEEZO J-Code J2403 from 1 to 2 units.
- Change allows billing for two vials of IHEEZO, supporting bilateral ocular procedures.
- Effective July 2024, with retroactive application to procedures from January 1, 2024.
- Company requested the change in February 2024 citing ophthalmologist need for bilateral use.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1360214/000149315224010740/0001493152-24-010740-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1360214/000149315224010740/form8-k.htm
  HTML page:      https://secwatch.observer/filing/0001493152-24-010740

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer